177 related articles for article (PubMed ID: 32554467)
1. The RAS-interacting chaperone UNC119 drives the RASSF6-MDM2-p53 axis and antagonizes RAS-mediated malignant transformation.
Shimizu T; Nakamura T; Inaba H; Iwasa H; Maruyama J; Arimoto-Matsuzaki K; Nakata T; Nishina H; Hata Y
J Biol Chem; 2020 Aug; 295(32):11214-11230. PubMed ID: 32554467
[TBL] [Abstract][Full Text] [Related]
2. UNC119 is a binding partner of tumor suppressor Ras-association domain family 6 and induces apoptosis and cell cycle arrest by MDM2 and p53.
Iwasa H; Sarkar A; Shimizu T; Sawada T; Hossain S; Xu X; Maruyama J; Arimoto-Matsuzaki K; Withanage K; Nakagawa K; Kurihara H; Kuroyanagi H; Hata Y
Cancer Sci; 2018 Sep; 109(9):2767-2780. PubMed ID: 29931788
[TBL] [Abstract][Full Text] [Related]
3. Domain analysis of Ras-association domain family member 6 upon interaction with MDM2.
Sarkar A; Iwasa H; Hossain S; Xu X; Sawada T; Shimizu T; Maruyama J; Arimoto-Matsuzaki K; Hata Y
FEBS Lett; 2017 Jan; 591(2):260-272. PubMed ID: 28054709
[TBL] [Abstract][Full Text] [Related]
4. The RASSF6 tumor suppressor protein regulates apoptosis and the cell cycle via MDM2 protein and p53 protein.
Iwasa H; Kudo T; Maimaiti S; Ikeda M; Maruyama J; Nakagawa K; Hata Y
J Biol Chem; 2013 Oct; 288(42):30320-30329. PubMed ID: 24003224
[TBL] [Abstract][Full Text] [Related]
5. BCL-XL binds and antagonizes RASSF6 tumor suppressor to suppress p53 expression.
Xu X; Iwasa H; Hossain S; Sarkar A; Maruyama J; Arimoto-Matsuzaki K; Hata Y
Genes Cells; 2017 Dec; 22(12):993-1003. PubMed ID: 29193479
[TBL] [Abstract][Full Text] [Related]
6. DNA Damage Triggers the Nuclear Accumulation of RASSF6 Tumor Suppressor Protein via CDK9 and BAF53 To Regulate p53 Target Gene Transcription.
Kuleape JA; Hossain S; Sinclear CK; Shimizu T; Iwasa H; Maruyama J; Arimoto-Matsuzaki K; Nishina H; Hata Y
Mol Cell Biol; 2022 Feb; 42(2):e0031021. PubMed ID: 34898277
[TBL] [Abstract][Full Text] [Related]
7. The RASSF6 Tumor Suppressor Protein Regulates Apoptosis and Cell Cycle Progression via Retinoblastoma Protein.
Hossain S; Iwasa H; Sarkar A; Maruyama J; Arimoto-Matsuzaki K; Hata Y
Mol Cell Biol; 2018 Sep; 38(17):. PubMed ID: 29891515
[TBL] [Abstract][Full Text] [Related]
8. Characterization of mouse embryonic fibroblasts derived from Rassf6 knockout mice shows the implication of Rassf6 in the regulation of NF-κB signaling.
Morishita M; Arimoto-Matsuzaki K; Kitamura M; Niimura K; Iwasa H; Maruyama J; Hiraoka Y; Yamamoto K; Kitagawa M; Miyamura N; Nishina H; Hata Y
Genes Cells; 2021 Dec; 26(12):999-1013. PubMed ID: 34652874
[TBL] [Abstract][Full Text] [Related]
9. RASSF6; the Putative Tumor Suppressor of the RASSF Family.
Iwasa H; Jiang X; Hata Y
Cancers (Basel); 2015 Dec; 7(4):2415-26. PubMed ID: 26690221
[TBL] [Abstract][Full Text] [Related]
10. Ras-association domain family protein 6 induces apoptosis via both caspase-dependent and caspase-independent pathways.
Ikeda M; Hirabayashi S; Fujiwara N; Mori H; Kawata A; Iida J; Bao Y; Sato Y; Iida T; Sugimura H; Hata Y
Exp Cell Res; 2007 Apr; 313(7):1484-95. PubMed ID: 17367779
[TBL] [Abstract][Full Text] [Related]
11. ASPP1 and ASPP2 bind active RAS, potentiate RAS signalling and enhance p53 activity in cancer cells.
Wang Y; Godin-Heymann N; Dan Wang X; Bergamaschi D; Llanos S; Lu X
Cell Death Differ; 2013 Apr; 20(4):525-34. PubMed ID: 23392125
[TBL] [Abstract][Full Text] [Related]
12. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
[TBL] [Abstract][Full Text] [Related]
13. Hippo pathway-dependent and -independent roles of RASSF6.
Ikeda M; Kawata A; Nishikawa M; Tateishi Y; Yamaguchi M; Nakagawa K; Hirabayashi S; Bao Y; Hidaka S; Hirata Y; Hata Y
Sci Signal; 2009 Sep; 2(90):ra59. PubMed ID: 19797269
[TBL] [Abstract][Full Text] [Related]
14. GRWD1 negatively regulates p53 via the RPL11-MDM2 pathway and promotes tumorigenesis.
Kayama K; Watanabe S; Takafuji T; Tsuji T; Hironaka K; Matsumoto M; Nakayama KI; Enari M; Kohno T; Shiraishi K; Kiyono T; Yoshida K; Sugimoto N; Fujita M
EMBO Rep; 2017 Jan; 18(1):123-137. PubMed ID: 27856536
[TBL] [Abstract][Full Text] [Related]
15. F-box protein FBXO31 modulates apoptosis and epithelial-mesenchymal transition of cervical cancer via inactivation of the PI3K/AKT-mediated MDM2/p53 axis.
Liu K; Xue B; Bai G; Zhang W
Life Sci; 2020 Oct; 259():118277. PubMed ID: 32800832
[TBL] [Abstract][Full Text] [Related]
16. Negative regulation of p53 by Ras superfamily protein RBEL1A.
Lui K; An J; Montalbano J; Shi J; Corcoran C; He Q; Sun H; Sheikh MS; Huang Y
J Cell Sci; 2013 Jun; 126(Pt 11):2436-45. PubMed ID: 23572512
[TBL] [Abstract][Full Text] [Related]
17. RASSF6-TRIM16 axis promotes cell proliferation, migration and invasion in esophageal squamous cell carcinoma.
Zheng L; Zhao Z; Rong L; Xue L; Song Y
J Genet Genomics; 2019 Oct; 46(10):477-488. PubMed ID: 31812473
[TBL] [Abstract][Full Text] [Related]
18. RASSF6 is a novel member of the RASSF family of tumor suppressors.
Allen NP; Donninger H; Vos MD; Eckfeld K; Hesson L; Gordon L; Birrer MJ; Latif F; Clark GJ
Oncogene; 2007 Sep; 26(42):6203-11. PubMed ID: 17404571
[TBL] [Abstract][Full Text] [Related]
19. The GTPase KRAS suppresses the p53 tumor suppressor by activating the NRF2-regulated antioxidant defense system in cancer cells.
Yang H; Xiang S; Kazi A; Sebti SM
J Biol Chem; 2020 Mar; 295(10):3055-3063. PubMed ID: 32001619
[TBL] [Abstract][Full Text] [Related]
20. The oncoprotein HBXIP modulates the feedback loop of MDM2/p53 to enhance the growth of breast cancer.
Li H; Liu Q; Wang Z; Fang R; Shen Y; Cai X; Gao Y; Li Y; Zhang X; Ye L
J Biol Chem; 2015 Sep; 290(37):22649-61. PubMed ID: 26229107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
